rs72554356

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 3P and 4B. PM1PP2BS2

The NM_000531.6(OTC):​c.374C>T​(p.Thr125Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000153 in 1,175,056 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T125T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000090 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000016 ( 0 hom. 11 hem. )

Consequence

OTC
NM_000531.6 missense

Scores

1
6
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts P:1U:8

Conservation

PhyloP100: -0.465

Publications

13 publications found
Variant links:
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]
OTC Gene-Disease associations (from GenCC):
  • ornithine carbamoyltransferase deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM1
In a hotspot region, there are 13 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 10 uncertain in NM_000531.6
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 266 curated pathogenic missense variants (we use a threshold of 10). The gene has 15 curated benign missense variants. Gene score misZ: 1.3274 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to ornithine carbamoyltransferase deficiency.
BS2
High Hemizygotes in GnomAdExome4 at 11 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTCNM_000531.6 linkc.374C>T p.Thr125Met missense_variant Exon 4 of 10 ENST00000039007.5 NP_000522.3
OTCNM_001407092.1 linkc.374C>T p.Thr125Met missense_variant Exon 6 of 12 NP_001394021.1
OTCXM_017029556.2 linkc.374C>T p.Thr125Met missense_variant Exon 4 of 9 XP_016885045.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTCENST00000039007.5 linkc.374C>T p.Thr125Met missense_variant Exon 4 of 10 1 NM_000531.6 ENSP00000039007.4
ENSG00000250349ENST00000465127.1 linkc.172-284704C>T intron_variant Intron 3 of 8 5 ENSP00000417050.1

Frequencies

GnomAD3 genomes
AF:
0.00000898
AC:
1
AN:
111307
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000327
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000110
AC:
2
AN:
182605
AF XY:
0.0000298
show subpopulations
Gnomad AFR exome
AF:
0.0000762
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000723
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000160
AC:
17
AN:
1063696
Hom.:
0
Cov.:
26
AF XY:
0.0000331
AC XY:
11
AN XY:
332178
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25796
American (AMR)
AF:
0.0000285
AC:
1
AN:
35149
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19150
East Asian (EAS)
AF:
0.0000332
AC:
1
AN:
30079
South Asian (SAS)
AF:
0.0000375
AC:
2
AN:
53280
European-Finnish (FIN)
AF:
0.0000247
AC:
1
AN:
40469
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4040
European-Non Finnish (NFE)
AF:
0.0000111
AC:
9
AN:
810751
Other (OTH)
AF:
0.0000667
AC:
3
AN:
44982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000898
AC:
1
AN:
111360
Hom.:
0
Cov.:
23
AF XY:
0.0000298
AC XY:
1
AN XY:
33594
show subpopulations
African (AFR)
AF:
0.0000327
AC:
1
AN:
30609
American (AMR)
AF:
0.00
AC:
0
AN:
10447
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3568
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2645
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5910
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53109
Other (OTH)
AF:
0.00
AC:
0
AN:
1513
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.0000165
AC:
2
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Ornithine carbamoyltransferase deficiency Uncertain:4
Dec 10, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Neuberg Centre For Genomic Medicine, NCGM
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The missense variant c.374C>T (p.Thr125Met) in OTC has been submitted to ClinVar as a Variant of Uncertain Significance. This variant has been observed in an individual affected with OTC deficiency (Gilbert-Dussardier B et al). Experimental studies have shown that this missense change causes lack of OTC enzymatic activity in vitro (Suriano G et al) This p.Thr125Met variant has allele frequency of 0.001095% in the gnomAD and novel (not in any individuals) in 1000 genome database. The amino acid Thr at position 125 is changed to a Met changing protein sequence and it might alter its composition and physico-chemical properties. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. For these reasons, this variant has been classified as Uncertain Significance (VUS). -

Jul 06, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 125 of the OTC protein (p.Thr125Met). This variant is present in population databases (rs72554356, gnomAD 0.008%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with OTC deficiency (PMID: 8807340). ClinVar contains an entry for this variant (Variation ID: 97175). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt OTC protein function. Experimental studies have shown that this missense change affects OTC function (PMID: 17613537). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Pathogenic:1Uncertain:2
-
GenMed Metabolism Lab
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Feb 01, 2018
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 11, 2020
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Published functional studies demonstrate that the T125M variant has reduced activity compared to wild type (Suriano et al., 2007); Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); In silico analysis supports that this missense variant does not alter protein structure/function; Identified in an individual with OTC deficiency by enzyme results, however full sequencing of OTC gene was not performed (Gilbert-Dussardier et al., 1996); This variant is associated with the following publications: (PMID: 17613537, 25637381, 27703146, 8807340, 28324312, 9452049) -

not specified Uncertain:1
Jul 28, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: OTC c.374C>T (p.Thr125Met) results in a non-conservative amino acid change located in the carbamoyl-P binding domain (IPR006132) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.1e-05 in 182605 control chromosomes, including 2 hemizygotes, suggesting the variant may be benign. c.374C>T has been reported in the literature as a hemizygous genotype in at least one individual affected with neonatal onset Ornithine Transcarbamylase Deficiency who also had two unaffected female relatives who carried the variant, however X-inactivation pattern was not reported in these individuals (e.g. Gilbert-Dussardier_1996, Gobin-Limballe_2021). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function and found the variant results in little to no enzyme activity compared to the WT protein (Suriano_2007). The following publications have been ascertained in the context of this evaluation (PMID: 25637381, 8807340, 34014569, 17613537). Five submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -

Hyperammonemia Uncertain:1
Jun 01, 2014
CSER _CC_NCGL, University of Washington
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

Low GERP score may suggest that this variant may belong in a lower pathogenicity class -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Pathogenic
0.15
CADD
Benign
0.62
DANN
Benign
0.92
DEOGEN2
Uncertain
0.68
D
FATHMM_MKL
Benign
0.039
N
LIST_S2
Benign
0.85
T
M_CAP
Uncertain
0.11
D
MetaRNN
Uncertain
0.66
D
MetaSVM
Uncertain
0.25
D
MutationAssessor
Benign
1.3
L
PhyloP100
-0.47
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.67
N
REVEL
Uncertain
0.59
Sift
Benign
0.12
T
Sift4G
Benign
0.22
T
Polyphen
0.69
P
Vest4
0.76
MVP
0.99
MPC
0.40
ClinPred
0.027
T
GERP RS
-3.0
Varity_R
0.13
gMVP
0.68
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72554356; hg19: chrX-38240670; API